Polyclonal Rabbit anti‑Rat GRIN1 / NMDAR1 Antibody (C‑Terminus, WB) LS‑C16882
Polyclonal Rabbit anti‑Rat GRIN1 / NMDAR1 Antibody (C‑Terminus, WB) LS‑C16882
Antibody:
GRIN1 / NMDAR1 Rabbit anti-Rat Polyclonal (C-Terminus) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
GRIN1 / NMDAR1 Rabbit anti-Rat Polyclonal (C-Terminus) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
NMDAR1 antibody LS-C16882 is an unconjugated rabbit polyclonal antibody to rat NMDAR1 (GRIN1) (C-Terminus). Validated for WB.
Target
Rat GRIN1 / NMDAR1
Synonyms
GRIN1 | GluN1 | NMDAR1 | NR1 | MRD8 | NMD-R1 | NMDA receptor A1 | NMDA1 | NR1a | GluR zeta 1 | N-methyl-D aspartate receptor
Reactivity
Rat
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Affinity purified
Immunogen
Peptide corresponding to the C-Terminus of rat NMDAR1 C2 splice variant.
Specificity
Specific for the NMDAR1 C2 splice variant. By Western blot recognizes a protein with MW of 100kD. Species Reactivity: Rat.
Usage
Western blot: 1:2000 using ECL.
Reconstitution
Reconstitute in deionized water
Storage
Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Monkey, Mouse, Rat
Applications:
IHC, IHC - Frozen, Western blot, ELISA
Species:
Rat, Human, Monkey, Mouse, Hamster
Applications:
IHC, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Rat
Applications:
ICC, Western blot, Immunoprecipitation
Species:
Human, Mouse, Rat
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 3/28/2024